# Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic Trauma

> **NCT05292001** · PHASE4 · RECRUITING · sponsor: **Oregon Health and Science University** · enrollment: 150 (estimated)

## Conditions studied

- Acute Blood Loss Anemia
- Fracture

## Interventions

- **DRUG:** Iron-Dextran Complex Injection [InFed]
- **OTHER:** Saline Placebo

## Key facts

- **NCT ID:** NCT05292001
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-01
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-08-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05292001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05292001, "Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic Trauma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05292001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*